查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1352871

全球基因組學人工智慧市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Artificial Intelligence in Genomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 335 Pages | 商品交期: 最快1-2個工作天內

價格

全球基因組市場對人工智慧的需求預計將從 2022 年的 11.3 億美元增至 2030 年的近 112.2 億美元，2023-2030 年研究期間複合年成長率為 33.3%。

基因組學中的人工智慧涉及在醫療保健領域利用機器學習來診斷和理解遺傳性疾病。基因組學中的人工智慧可以幫助醫療保健專業人員更好地了解癌症等致命疾病以及患者的幾種罕見和退化性疾病。人工智慧有助於建立基因組數據，這比透過人類干預更快解釋疾病有很大幫助。它可以更快地分析遺傳物質的結構、功能和發育。

市場動態：

基因組學市場中的人工智慧在預測期內顯示出令人滿意的成長率。基因組學在個人化醫療中的作用將有助於該市場的成長，因為人工智慧的應用有助於更快地製造藥品。公共和私營部門組織減少藥物開發時間和成本以及增加對基因組學人工智慧投資的必要性促進了市場的成長。此外，日益成長的精準醫療製造是另一個市場成長動力，重點在於遺傳、生活方式和環境在人類疾病中的作用。同樣，在開藥之前使用患者的基因圖譜來發現患者個體需求的個人化醫療方法可能會影響基因組學市場中人工智慧的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球基因組學人工智慧市場的各個細分市場進行了包容性評估。基因組學產業人工智慧的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲基因組學市場人工智慧當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。基因組學市場人工智慧的主要參與者包括IBM（美國）、微軟（美國）、NVIDIA公司（美國）、Deep Genomics（加拿大）、BenevolentAI（英國）、Fabric Genomics Inc.（美國）、Verge Genomics（美國） )、Freenome Holdings, Inc.（美國）、MolecularMatch Inc.（美國）、Cambridge Cancer Genomics（英國）、SOPHiA GENETICS（美國）、Data4Cure Inc.（美國）、PrecisionLife Ltd（英國）、Genoox Ltd.（美國） 、Lifebit（英國）、Diploid（比利時）、FDNA Inc.（美國）、DNAnexus Inc.（美國）、Empiric Logic（愛爾蘭）和Engine Biosciences Pte.有限公司（美國）。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：基因組學中的人工智慧 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品提供的市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 按功能分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

5 COVID-19 爆發的影響分析

  • Covid-19 爆發的影響分析
    • 對生產的直接影響
    • 供應鍊和市場顛覆
    • 對公司和金融市場的財務影響
  • 按生產、進口、出口和需求分類的 COVID-19 影響分析
  • 市場：COVID-19 前 V/S 後
  • 冠狀病毒 (COVID-19) 疫情的預期影響
  • COVID-19：微觀和宏觀因素分析

第 6 章：全球人工智慧基因組市場分析：透過提供

  • 按產品分類概述
  • 歷史和預測數據
  • 按產品分析
  • 軟體
  • 服務

第 7 章：全球人工智慧基因組市場分析：按技術分類

  • 依技術概述
  • 歷史和預測數據
  • 依技術分析
  • 機器學習
  • 深度學習
  • 監督學習
  • 強化學習
  • 無監督學習
  • 其他機器學習技術
  • 其他技術

第 8 章：全球人工智慧基因組市場分析：按功能分類

  • 按功能概述
  • 歷史和預測數據
  • 按功能分析
  • 基因組定序
  • 基因編輯
  • 臨床工作流程
  • 預測基因檢測與預防醫學

第 9 章：全球人工智慧在基因組學市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 診斷
  • 藥物發現與開發
  • 精準醫療
  • 農業與動物研究
  • 其他應用

第 10 章：全球人工智慧基因組市場分析：按最終用戶分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 製藥與生物技術公司
  • 醫療保健機構
  • 研究中心、學術機構
  • 政府機構
  • 其他最終用戶

第 11 章：全球人工智慧基因組市場分析：按地理位置

  • 頂尖公司股票分析
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 12 章：基因組公司人工智慧的競爭格局

  • 基因組市場競爭中的人工智慧
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 13 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • IBM (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Microsoft (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • NVIDIA Corporation (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Deep Genomics (Canada)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BenevolentAI (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Fabric Genomics Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Verge Genomics (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Freenome Holdings Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • MolecularMatch Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cambridge Cancer Genomics (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • SOPHiA GENETICS (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Data4Cure Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • PrecisionLife Ltd (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Genoox Ltd. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lifebit (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Diploid (Belgium)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • FDNA Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • DNAnexus Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Empiric Logic (Ireland)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Engine Biosciences Pte. Ltd. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR11218912

The global demand for Artificial Intelligence in Genomics Market is presumed to reach the market size of nearly USD 11.22 BN by 2030 from USD 1.13 BN in 2022 with a CAGR of 33.3% under the study period 2023 - 2030.

Artificial Intelligence in Genomics involves the utilization of machine learning in the field of healthcare to diagnose and understand genetic disorders. AI in genomics helps healthcare professionals to understand better deadly diseases like cancer and several rare and degenerative conditions in patients. AI helps in the structuring of genomic data, and this helps a great deal in interpreting diseases faster than doing it through human intervention. It enables a faster analysis of the structure, functioning and development of the genetic materials.

MARKET DYNAMICS:

Artificial Intelligence in Genomics market shows a satisfactory growth rate during the projection period. The role of genomics in personalized medicine will help the growth of this market as the application of AI helps in the faster manufacturing of medicines. The necessity to reduce time and cost in drug development and increase investments made in AI in genomics by the public and private sector organizations have contributed to the market's growth. Moreover, the growing manufacturing of precision medicine, which focuses on the role of genetics, lifestyle, and environment in the diseases in humans, is another market driver of growth. Similarly, the personalized medicine method that uses patients' genetic profiles to discover the individual patient requirements before prescribing medicine is likely to influence the growth of the AI in genomics market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of artificial intelligence in genomics. The growth and trends of artificial intelligence in genomics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the artificial intelligence in genomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Offering

  • Software
  • Services

By Technology

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

By Functionality

  • Genome Sequencing
  • Gene Editing
  • Clinical Workflows
  • Predictive Genetic Testing & Preventive Medicine

By Application

  • Diagnostics
  • Drug Discovery & Development
  • Precision Medicine
  • Agriculture & Animal Research
  • Other Applications

By End User

  • Pharmaceutical & Biotech Companies
  • Healthcare Providers
  • Research Centers, Academic Institutes
  • Government Organizations
  • Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Artificial Intelligence in Genomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the artificial intelligence in genomics market include IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK), Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), and Engine Biosciences Pte. Ltd. (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ARTIFICIAL INTELLIGENCE IN GENOMICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Offering
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Functionality
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY OFFERING

  • 6.1 Overview by Offering
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Offering
  • 6.4 Software Historic and Forecast Sales by Regions
  • 6.5 Services Historic and Forecast Sales by Regions

7 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY TECHNOLOGY

  • 7.1 Overview by Technology
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Technology
  • 7.4 Machine Learning Historic and Forecast Sales by Regions
  • 7.5 Deep Learning Historic and Forecast Sales by Regions
  • 7.6 Supervised Learning Historic and Forecast Sales by Regions
  • 7.7 Reinforcement Learning Historic and Forecast Sales by Regions
  • 7.8 Unsupervised Learning Historic and Forecast Sales by Regions
  • 7.9 Other Machine Learning Technologies Historic and Forecast Sales by Regions
  • 7.10. Other Technologies Historic and Forecast Sales by Regions

8 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY FUNCTIONALITY

  • 8.1 Overview by Functionality
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Functionality
  • 8.4 Genome Sequencing Historic and Forecast Sales by Regions
  • 8.5 Gene Editing Historic and Forecast Sales by Regions
  • 8.6 Clinical Workflows Historic and Forecast Sales by Regions
  • 8.7 Predictive Genetic Testing & Preventive Medicine Historic and Forecast Sales by Regions

9 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Diagnostics Historic and Forecast Sales by Regions
  • 9.5 Drug Discovery & Development Historic and Forecast Sales by Regions
  • 9.6 Precision Medicine Historic and Forecast Sales by Regions
  • 9.7 Agriculture & Animal Research Historic and Forecast Sales by Regions
  • 9.8 Other Applications Historic and Forecast Sales by Regions

10 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY END USER

  • 10.1 Overview by End User
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End User
  • 10.4 Pharmaceutical & Biotech Companies Historic and Forecast Sales by Regions
  • 10.5 Healthcare Providers Historic and Forecast Sales by Regions
  • 10.6 Research Centers, Academic Institutes Historic and Forecast Sales by Regions
  • 10.7 Government Organizations Historic and Forecast Sales by Regions
  • 10.8 Other End Users Historic and Forecast Sales by Regions

11 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE ARTIFICIAL INTELLIGENCE IN GENOMICS COMPANIES

  • 12.1. Artificial Intelligence In Genomics Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF ARTIFICIAL INTELLIGENCE IN GENOMICS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. IBM (US)
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Microsoft (US)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. NVIDIA Corporation (US)
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Deep Genomics (Canada)
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. BenevolentAI (UK)
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Fabric Genomics Inc. (US)
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Verge Genomics (US)
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Freenome Holdings Inc. (US)
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. MolecularMatch Inc. (US)
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Cambridge Cancer Genomics (UK)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. SOPHiA GENETICS (US)
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Data4Cure Inc. (US)
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. PrecisionLife Ltd (UK)
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments
  • 13.16. Genoox Ltd. (US)
    • 13.16.1. Company Overview
    • 13.16.2. Company Revenue
    • 13.16.3. Products
    • 13.16.4. Recent Developments
  • 13.17. Lifebit (UK)
    • 13.17.1. Company Overview
    • 13.17.2. Company Revenue
    • 13.17.3. Products
    • 13.17.4. Recent Developments
  • 13.18. Diploid (Belgium)
    • 13.18.1. Company Overview
    • 13.18.2. Company Revenue
    • 13.18.3. Products
    • 13.18.4. Recent Developments
  • 13.19. FDNA Inc. (US)
    • 13.19.1. Company Overview
    • 13.19.2. Company Revenue
    • 13.19.3. Products
    • 13.19.4. Recent Developments
  • 13.20. DNAnexus Inc. (US)
    • 13.20.1. Company Overview
    • 13.20.2. Company Revenue
    • 13.20.3. Products
    • 13.20.4. Recent Developments
  • 13.21. Empiric Logic (Ireland)
    • 13.21.1. Company Overview
    • 13.21.2. Company Revenue
    • 13.21.3. Products
    • 13.21.4. Recent Developments
  • 13.22. Engine Biosciences Pte. Ltd. (US)
    • 13.22.1. Company Overview
    • 13.22.2. Company Revenue
    • 13.22.3. Products
    • 13.22.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Offering (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Technology (USD MN)
  • Machine Learning Market Sales by Geography (USD MN)
  • Deep Learning Market Sales by Geography (USD MN)
  • Supervised Learning Market Sales by Geography (USD MN)
  • Reinforcement Learning Market Sales by Geography (USD MN)
  • Unsupervised Learning Market Sales by Geography (USD MN)
  • Other Machine Learning Technologies Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Analysis by Functionality (USD MN)
  • Genome Sequencing Market Sales by Geography (USD MN)
  • Gene Editing Market Sales by Geography (USD MN)
  • Clinical Workflows Market Sales by Geography (USD MN)
  • Predictive Genetic Testing & Preventive Medicine Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Diagnostics Market Sales by Geography (USD MN)
  • Drug Discovery & Development Market Sales by Geography (USD MN)
  • Precision Medicine Market Sales by Geography (USD MN)
  • Agriculture & Animal Research Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Pharmaceutical & Biotech Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Research Centers, Academic Institutes Market Sales by Geography (USD MN)
  • Government Organizations Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Artificial Intelligence In Genomics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Artificial Intelligence In Genomics Report
  • Market Research Process
  • Market Research Methodology
  • Global Artificial Intelligence In Genomics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Offering
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Functionality
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Offering (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Machine Learning Market Sales by Geography (USD MN)
  • Deep Learning Market Sales by Geography (USD MN)
  • Supervised Learning Market Sales by Geography (USD MN)
  • Reinforcement Learning Market Sales by Geography (USD MN)
  • Unsupervised Learning Market Sales by Geography (USD MN)
  • Other Machine Learning Technologies Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Global Market Analysis by Functionality (USD MN)
  • Genome Sequencing Market Sales by Geography (USD MN)
  • Gene Editing Market Sales by Geography (USD MN)
  • Clinical Workflows Market Sales by Geography (USD MN)
  • Predictive Genetic Testing & Preventive Medicine Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Diagnostics Market Sales by Geography (USD MN)
  • Drug Discovery & Development Market Sales by Geography (USD MN)
  • Precision Medicine Market Sales by Geography (USD MN)
  • Agriculture & Animal Research Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Pharmaceutical & Biotech Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Research Centers, Academic Institutes Market Sales by Geography (USD MN)
  • Government Organizations Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.